DD
Divya Damodaran Nambissan
About Divya Damodaran Nambissan
Data last updated:
Divya Damodaran Nambissan is a Designated Partner at Ressaar Global Llp (since 2025) and Designated Partner at Medi Research Direct Llp (since 2020). The companies operate in Research & Development.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 07 May 2025 | 2025 | Active | ||
| Designated Partner | 13 Mar 2020 | 2018 | Active |
Board colleagues of Divya Damodaran Nambissan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Puthanveettil Mirshad | 08721421 | Ressaar Global Llp , Medi Research Direct Llp | Designated Partner |
| Sahal Rahman | 10912363 | Ressaar Global Llp | Designated Partner |
| Tharayil Kattil Jithesh | 08008162 | Ressaar Global Llp , Medi Research Direct Llp | Designated Partner |
| Fasalu Rahiman | 08008142 | Medi Research Direct Llp | Designated Partner |
| Riju Mathew | 08721486 | Medi Research Direct Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Divya Damodaran Nambissan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Divya Damodaran Nambissan
Divya Damodaran Nambissan currently holds 2 directorships: Ressaar Global Llp (Designated Partner, since 07 May 2025); Medi Research Direct Llp (Designated Partner, since 13 Mar 2020).
Divya Damodaran Nambissan was first appointed on 13 Mar 2020 as Designated Partner at Medi Research Direct Llp. The most recent appointment on record is 07 May 2025 at Ressaar Global Llp.
The current boards of Divya Damodaran Nambissan's companies include Puthanveettil Mirshad (Ressaar Global Llp), Sahal Rahman (Ressaar Global Llp), Tharayil Kattil Jithesh (Ressaar Global Llp), Fasalu Rahiman (Medi Research Direct Llp), Riju Mathew (Medi Research Direct Llp).